These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9703470)

  • 1. Syntheses and structure-activity relationships of novel retinoid X receptor agonists.
    Hibi S; Kikuchi K; Yoshimura H; Nagai M; Tai K; Hida T
    J Med Chem; 1998 Aug; 41(17):3245-52. PubMed ID: 9703470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.
    Beard RL; Colon DF; Song TK; Davies PJ; Kochhar DM; Chandraratna RA
    J Med Chem; 1996 Aug; 39(18):3556-63. PubMed ID: 8784454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids.
    Michellys PY; Ardecky RJ; Chen JH; D'Arrigo J; Grese TA; Karanewsky DS; Leibowitz MD; Liu S; Mais DA; Mapes CM; Montrose-Rafizadeh C; Ogilvie KM; Reifel-Miller A; Rungta D; Thompson AW; Tyhonas JS; Boehm MF
    J Med Chem; 2003 Sep; 46(19):4087-103. PubMed ID: 12954061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and structure-activity relationship of novel RXR-selective modulators.
    Michellys PY; D'Arrigo J; Grese TA; Karanewsky DS; Leibowitz MD; Mais DA; Mapes CM; Reifel-Miller A; Rungta D; Boehm MF
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1593-8. PubMed ID: 15006411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.
    Canan Koch SS; Dardashti LJ; Cesario RM; Croston GE; Boehm MF; Heyman RA; Nadzan AM
    J Med Chem; 1999 Feb; 42(4):742-50. PubMed ID: 10052980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenylamine-based retinoid antagonists: regulation of RAR and RXR function depending on the N-substituent.
    Ohta K; Kawachi E; Fukasawa H; Shudo K; Kagechika H
    Bioorg Med Chem; 2011 Apr; 19(8):2501-7. PubMed ID: 21459577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
    Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
    Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.
    Yu KL; Spinazze P; Ostrowski J; Currier SJ; Pack EJ; Hammer L; Roalsvig T; Honeyman JA; Tortolani DR; Reczek PR; Mansuri MM; Starrett JE
    J Med Chem; 1996 Jun; 39(12):2411-21. PubMed ID: 8691435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
    Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
    J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the first retinoid X, receptor homodimer antagonist.
    Canan Koch SS; Dardashti LJ; Hebert JJ; White SK; Croston GE; Flatten KS; Heyman RA; Nadzan AM
    J Med Chem; 1996 Aug; 39(17):3229-34. PubMed ID: 8765503
    [No Abstract]   [Full Text] [Related]  

  • 11. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.
    Osburn DL; Shao G; Seidel HM; Schulman IG
    Mol Cell Biol; 2001 Aug; 21(15):4909-18. PubMed ID: 11438648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of potent retinoid X receptor alpha agonists.
    Haffner CD; Lenhard JM; Miller AB; McDougald DL; Dwornik K; Ittoop OR; Gampe RT; Xu HE; Blanchard S; Montana VG; Consler TG; Bledsoe RK; Ayscue A; Croom D
    J Med Chem; 2004 Apr; 47(8):2010-29. PubMed ID: 15056000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
    Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
    Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin.
    Kambayashi H; Odake Y; Takada K; Funasaka Y; Ichihashi M; Kato S
    Br J Dermatol; 2005 Dec; 153 Suppl 2():30-6. PubMed ID: 16280019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
    Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
    Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
    Lefebvre P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective RXR modulators for the treatment of type II diabetes.
    Faul MM; Grese TA
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
    Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
    Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.